medigraphic.com

2004, Number 2

<< Back Next >>

Arch Cardiol Mex 2004; 74 (2)

Study of Magnolia grandiflora extracts in guinea pigs cardiac muscle

Valle ML, Tenorio LFA, Torres NJC, Zarco OG, Pastelín HG

Language: Spanish
References: 51
Page: 108-117
PDF size: 159.40 Kb.


ABSTRACT

Several extracts from diverse Magnolia grandiflora varieties were pharmacological evaluated in the cardiac muscle. From March to July, flowers and leaves from Magnolia grandiflora, native from the National Institute of Cardiology “Ignacio Chávez”, from north, west, and orient zones from Mexico City, and from Puebla, Colima and Chiapas states were collected. They were separately processed and the extracts were obtained by maceration with ethanol-water (1:3 v/v) at 4°C during two weeks. Qualitative analysis was accomplished with thin-layer, column and high-performance liquid chromatographies (HPLC). Functional and molecular analysis was made by specific chemical reactivity and by protonic magnetic resonance (RMN 1H). Pharmacological evaluation was completed in isolated and perfused male guinea pigs hearts. Extracts, fractions, and compounds were administrated by serial bolus in a gradual dose-response curves study in which left intraventricular pressure and coronary perfusion pressure were recorded, evaluating by such the positive inotropic and vasodilator effects of Magnolia grandiflora extracts. Vulgarenol and 2-p-hydroxyphenyl-2-hydroxy-ethylamine were isolated and identified, and the obtained results suggest that its positive inotropic and vasodilator effects are owed to these substances, being complemented by magnograndiolide and tyramine.


REFERENCES

  1. Linneo C: Systema naturae. 10th ed. Londres. Vol. 2, 1759. p 1082-1090.

  2. de Micheli-Serra A: Acerca de la terapéutica digitálica. Bosquejo histórico. Gac Méd Méx 2000; 136(5): 511-518.

  3. Krieger L: Indigenous folk botany. Nederland. Time-Life International, 1965. p 45-62.

  4. Kelly I: Folk practices in North Mexico. In: Latin American Monographs. No. 2, Institute of Latin American Studies. The University of Texas, Texas.1965. p 84-90.

  5. Mellado V, Chavez SMA, Lozoya X: Pharmacological screening of the aqueous extracts of Magnolia grandiflora L. Arch Invest Med 1980; 11: 335-346.

  6. Pérez CR, Roca J: Contribución al estudio de la Farmacología del Yolloxóchitl (Talauma mexicana). Arch Latinamer Cardiol Hematol 1937; VII: 87-92.

  7. Pérez CR, Roca J: Acción sobre el trabajo del corazón y sobre la circulación coronaria de los extractos acuosos de hojas de Yolloxóchitl (Talauma mexicana). Arch Latinamer Cardiol Hematol 1938; VIII: 109-115.

  8. Matsutani H, Shiba T: Tyramine from magnolia species. Phytochemistry 1975; 14: 1132-1140.

  9. Vourinen H, Määttä K, Törrönen R: Content of the flavonols myricetin, quercetin, and kaempherol in Magnolia grandiflora. J Agric Food Med 2000; 48: 2675-2680.

  10. Poliam A, Lara M, Rodhanny G: Actividad estimulante de la fracción de saponósidos terpénicos de las Magnoliáceas. Rev Cubana Plant Med 1996; 1(4): 11-15.

  11. Tatsuhiko N: Studies of the alkaloids of magnoliaceous plants. XII. Alkaloids of Magnolia grandiflora L. Pharm Bull 1954; 2: 31-328.

  12. Gora J, Kalemba D, Kurowska A: Chemical substances of Magnoliaceas and Calendulaceas. Herba Hungarica 1980; 19: 151-171.

  13. Juneau RI: A new glycoside from the bark of Magnolia grandiflora. Dis Abst Int 1973; 33: 3013-3015.

  14. Luo XD, Wu SH, Ma YB, Wu DG, Zhou J: Sesquiterpenoids from Magnolia grandiflora. Planta Med 2001; 67: 354-357.

  15. Middleton E, Kandaswami C, Theoharides TC: The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000; 52: 673-751.

  16. Nady WT: Medical Experimental. 3rd Ed., New York, Oxford University Press, 1990. p 34-99.

  17. Hissa R, George C, Stevens ED, Saarela S: Thermoregulatory response to tyramine in the pigeon. Acta Physiol Scand 1980; 110: 175-180.

  18. Döring H, Dehnert H: The isolated perfused heart according to Langendorff. Friburgo de Brisgovia, Biomesstechnik-Verlag, 1988. p 1-70.

  19. Wulf EW: The world resources of the useful animals. Moscú, Nauka, 1972. p 21-96.

  20. Ramstad E: Pharmacognosy. New York, McGraw-Hill Book Company, 1956. p 419-449.

  21. Abderhalden E: Handbuch der biologischen arbeitsmethoden. Berlin, Urban & Schwarzenberg, 1957. p 1-156.

  22. Albers CC, Chambers MA: Laboratory Study Guide: General Pharmacognosy. Austin, Hemphill’s Bookstores, 1951. p 22-79.

  23. Block RJ, Durrum EL, Zweig G: Paper chromatography and Electrophoresis. 3rd Ed., New York, Academic Press, 1985. p 50-98.

  24. Linskens HF, Jackson JF: Liquid chromatography in plant sciences. Berlin, Springer, 1987. p 25-35, 56-90, 121-200.

  25. Golomm H, Feddor G: Practical HPL-Chromatography in Medicinal Plants. 3rd Ed., London, J. & A. Churchill, 1970. p 125-156.

  26. Touchstone JC, Sherma J: Techniques and applications of thin layer chromatography. New York, Wiley-Interscience, 1985. p 20-54.

  27. Siggia S: Quantitative Organic Analysis via Functional Groups. 4th Ed., New York, John Wiley and Sons, 1979. p 883.

  28. Zweig G, Sherma J: Spectroscopic Methods of Analysis. New York, Academic Press, 1977. p 297.

  29. Lemmedt T, Klauss W: The Nuclear Magnetic Resonance in Pharmacology. Philadelphia, Sonth-Hill, 1980. p 1-89, 160-201.

  30. Kiwalth R, Kimari O: Start of the Nuclear Magnetic Resonance. New York, D’Evan Nostrand, 1988. pp 324.

  31. Tatsime-Ohi K, Hiyamoto Y: Functional Analysis. New York, Shendo, 1989. p 7-51, 90-102.

  32. Shriner R, Fuson R, Curtin D, Morrill T: The Systematic Identification of Organic Compounds. 6th Ed., Toronto, John Wiley & Sons, 1980. pp 604.

  33. Feigl F, Anger V: Pruebas a la gota en análisis orgánico. México, El Manual Moderno, 1978. pp 772.

  34. Box G, Hunter W: Estadística para Investigadores: Introducción al Diseño de Experimentos, Análisis de Datos y Construcción de Modelos. 3a Ed., México, Reverté, 1999. p 345-580.

  35. Takauchi Y, Yamazaki T, Akiyama T: Tyramine-induced endogenous noradrenaline efflux from in situ cardiac sympathetic nerve ending in cats. Acta Physiol Scand 2000; 168: 287-293.

  36. Scott HJ, Donald PG, Fuller WR: In vivo cardiovascular responses to isoproterenol, dopamine and tyramine after prolonged infusion of isoproterenol. J Pharm Exp Ther 1984; 231(3): 633-639.

  37. Schäfer RF, Poller K, Geissler M, Daul AE, Michel MC, Brodle OE: Influence or adrenoceptor and receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine. Naunyn-Schmiedeberg’s Arch Pharmacol 1997; 355: 239-249.

  38. Kobayashi M, Shimotori M, Chiba S: Direct effects of catecholamines and tyramine on sinoatrial conduction in isolated and blood-perfused dog atria. Jpn Heart J 1984; 25(2): 195-205.

  39. Dzimiri N: Regulation of b-adrenoceptor signaling in cardiac function and disease. Pharm Rev 1999; 51(3): 465-501

  40. Romieu I, Borja-Aburto VH: Particulate air pollution and daily mortality: Can results be generalized to Latin American countries? Salud Publica Mex 1997; 39: 403-411.

  41. Calderón-Garcidueñas L, Valencia-Salazar G, Rodríguez-Alcaraz A, Gambling TM, García R, Osnaya N, et al: Ultrastructural Nasal Pathology in Children Chronically and Sequentially Exposed to Air Pollutants. Am J Respir Cell Mol Biol 2001; 24: 132-138.

  42. Romieu I, Meneses F, Ramírez M, Ruiz S, Pérez-Padilla R, Sienra JJ, et al: Antioxidant Supplementation and Respiratory Functions among Workers Exposed to High Levels of Ozone. Am J Respir Crit Care Med 1998; 158: 226-232.

  43. Calderón-Garciduenas L, Osnaya-Brizuela N, Ramírez-Martínez L, Villarreal-Calderón A: DNA strand breaks in human nasal respiratory epithelium are induced upon exposure to urban pollution. Environ Health Perspect 1996; 104(2): 160-8.

  44. Calderón-Garciduenas L, Roy-Ocotla G: Nasal cytology in southwest metropolitan Mexico City inhabitants: a pilot intervention study. Environ Health Perspect 1993; 101(2): 138-44.

  45. Jaimes L, Sandoval J: Propane and butane emission sources to ambient air of Mexico City metropolitan area. Sci Total Environ 2002; 289(1-3): 243-247.

  46. Sánchez-Carrillo CI, Cerón-Mireles P, Rojas-Martínez MR, Mendoza-Alvarado L, Olaiz-Fernández G, Borja-Aburto VH: Surveillance of acute health effects of air pollution in Mexico City. Epidemiology 2003; 14(5): 536-44.

  47. Tellez-Rojo MM, Romieu I, Ruiz-Velasco S, Lezana MA, Hernandez-Avila MM: Daily respiratory mortality and PM10 pollution in Mexico City: importance of considering place of death. Eur Respir J 2000; 16(3): 391-6.

  48. el-Feraly FS, Chan YM: Isolation and characterization of the sesquiterpene lactone costunolide, parthenolide, costunolide diepoxide, santamarine, and reynosin from Magnolia grandiflora L. J Pharm Sci 1978; 67(3): 347-350.

  49. Andersson M, Bergendorff O, Shan R, Zygmunt P, Sterner O: Minor components with muscle relaxing properties from scented myrrh. Planta Medica 1997; 63: 251-254.

  50. Koo TH, Lee JH, Park YJ, Hong YS, Kim HS, Kim KE, et al: A sesquiterpene lactone, costunolide, from Magnolia grandiflora inhibits HF-kB by targeting IkB phosphorylation. Planta Med 2001; 67(2): 103-107.

  51. Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP: Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol 2000; 184: 409-420.




2020     |     www.medigraphic.com